FTC's Take On Drug Sales To Rivals May Cost Pharma
By Melissa Lipman ( March 12, 2013, 9:35 PM EDT) -- The Federal Trade Commission on Monday urged a New Jersey court to keep alive a case accusing Actelion Pharmaceutical Ltd. of breaching antitrust laws by refusing to supply generic rivals with samples of drugs covered by rules restricting distribution, a move that could force pharmaceutical companies to fight out expensive litigation and extend to other industries like the high-tech sector....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.